Amelioration of systemic inflammation via the display of two different decoy protein receptors on extracellular vesiclesDhanu Gupta, Samir EL Andaloussi, Giulia Corso et al.|Nature Biomedical Engineering|2021Cited by 102
Pirtobrutinib targets BTK C481S in ibrutinib-resistant CLL but second-site BTK mutations lead to resistanceAishath Naeem, Jennifer R. Brown, Filippo Utro et al.|Blood Advances|2022Cited by 79